Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50
Benzinga Newsdesk 5 months ago
NewsUpgradesPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.
Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.
